Health Catalyst director awarded 128,851 stock units
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Health Catalyst, Inc. director Tami Reller acquired an award of 128,851 restricted stock units on October 1, 2026. Each RSU represents a contingent right to receive one common share. The transaction table reports a direct post-transaction position of 128,851 shares; the footnote identifies the award as RSUs. Under the 2019 Plan and the Non-Employee Director Compensation Policy, 33.33% vest on October 1, 2027, and the remaining 66.67% vest in two equal annual installments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 128,851 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on October 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.
Key Figures
Key Terms
restricted stock units financial
2019 Stock Option and Incentive Plan financial
contingent right technical
Non-Employee Director Compensation Policy financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many RSUs did HCAT director Tami Reller receive?
AI-generated analysis. How Rhea-AI works. Not financial advice.